Skip to main content
SpringerLink
Log in

Antipsychotic treatment of schizophrenia: Two steps forward, one step back

  • Invited Commentary
  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kane JM, Honigfeld G, Singer J, Meltzer HY: Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988, 45:789–796.

    PubMed  CAS  Google Scholar 

  2. Meltzer H Y, Alphs L, Green AI, et al.: Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry 2003, 60:82–91.

    PubMed  CAS  Google Scholar 

  3. Jibson MD, Tandon R: New atypical antipsychotic medications. J Psychiatr Res 1998, 32:215–228.

    Article  PubMed  CAS  Google Scholar 

  4. Miller AL, Hall CS, Buchanan RW, et al.: The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update. J Clin Psychiatry 2004, 65:500–508.

    Article  PubMed  Google Scholar 

  5. Falkai P, Wobrock T, Lieberman J, et al.: World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia. World J Biol Psychiatry 2005, 6:132–191.

    PubMed  Google Scholar 

  6. Procyshyn RM, Chau A, Fortin P, Jenkins W: Prevalence and outcomes of pharmaceutical industry-sponsored clinical trials involving clozapine, risperidone, and olanzapine. Can J Psychiatry 2004, 49:601–606.

    PubMed  Google Scholar 

  7. Heres S, Davis J, Maino K, et al.: Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics. Am J Psychiatry 2006, 163:185–194.

    Article  PubMed  Google Scholar 

  8. Lieberman JA, Stroup ST, McEvoy JP, et al.: Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005, 353:1209–1223.

    Article  PubMed  CAS  Google Scholar 

  9. Jones PB, Barnes TR, Davies L, et al.: Randomized controlled trial of effect on quality of life of second-vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Arch Gen Psychiatry 2006, 63:1079–1087.

    Article  PubMed  CAS  Google Scholar 

  10. Keefe RS: Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial. Paper presented at the 61st Society of Biological Psychiatry Annual Meeting. Toronto, Ontario; May 18–20, 2006.

  11. Swartz MS, Perkins DO, Stroup TS, et al.: Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study. Am J Psychiatry 2007, 164:428–436.

    Article  PubMed  Google Scholar 

  12. Constantine RJ, Tandon R: Antipsychotics equivalent? CUt-LASS renews the debate. Curr Psychiatry 2007, 6:58–78.

    Google Scholar 

  13. Gerlach J: Improving outcome in schizophrenia: the potential importance of EPS and neuroleptic dysphoria. Ann Clin Psychiatry 2002, 14:47–57.

    Article  PubMed  Google Scholar 

  14. Rosenheck R, Stroup ST, Keefe RS, et al.: Study samples key to assessing risk. The authors reply. Curr Psychiatry 2007, 6:3–19.

    Google Scholar 

  15. Tandon R, Jibson MD: Extrapyramidal side-effects of antipsychotic treatment: scope of problem and impact on outcome. Ann Clin Psychiatry 2002, 14:123–129.

    Article  PubMed  Google Scholar 

  16. Constantine RJ, Richard SM, Surles RC, et al.: Optimizing pharmacotherapy of schizophrenia: tools for the psychiatrist. Curr Psychosis Ther Rep 2006, 4:5–11.

    Google Scholar 

  17. Tandon R, Targum SD, Nasrallah HA, et al.: Strategies for maximizing clinical effectiveness in the treatment of schizophrenia. J Psychiatr Pract 2006, 12:348–363.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Room 235, Building 6, 1317 Winewood Boulevard, Tallahassee, FL, 32399-0700, USA

    Rajiv Tandon MD

Authors
  1. Rajiv Tandon MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rajiv Tandon MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tandon, R. Antipsychotic treatment of schizophrenia: Two steps forward, one step back. Curr Psychiatry Rep 9, 263–264 (2007). https://doi.org/10.1007/s11920-007-0029-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11920-007-0029-3

Keywords

Search

Navigation